工作日：以图书馆工作时间为准
节假日：服务受理时间顺延至工作日
ESI 数据报告
| 类型 | 入藏号 | 标题 作者 地址 | 来源出版物 | 出版年 | ESI 学科分类 | 引用 |
|---|---|---|---|---|---|---|
|
高被引论文
2024-03
|
WOS:000355246600046
MEDLINE:25981818 |
REGORAFENIB PLUS BEST SUPPORTIVE CARE VERSUS PLACEBO PLUS BEST SUPPORTIVE CARE IN ASIAN PATIENTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER (CONCUR): A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
DOI
LI, J;QIN, SK;XU, RH;YAU, TCC;MA, B;PAN, HM;XU, JM;BAI, YX;CHI, YHBL;WANG, LW;YEH, KH;BI, F;CHENG, Y;LE, AT;LIN, JK;LIU, TS;MA, D;KAPPELER, C;KALMUS, J;KIM, TW
ASAN MEDICAL CENTER;ZHEJIANG UNIVERSITY;UNIVERSITY OF ULSAN;UNIVERSITY OF HONG KONG;TAIPEI VETERANS GENERAL HOSPITAL;SUN YAT SEN UNIVERSITY;SICHUAN UNIVERSITY;SHANGHAI JIAO TONG UNIVERSITY;PRINCE OF WALES HOSPITAL;NATIONAL YANG MING CHIAO TUNG UNIVERSITY;NATIONAL TAIWAN UNIVERSITY HOSPITAL;NATIONAL TAIWAN UNIVERSITY;NANJING UNIVERSITY OF CHINESE MEDICINE;JILIN PROV TUMOR HOSP;HARBIN MEDICAL UNIVERSITY;GUANGDONG ACADEMY OF MEDICAL SCIENCES & GUANGDONG GENERAL HOSPITAL;FUDAN UNIVERSITY;CHO RAY HOSPITAL;CHINESE UNIVERSITY OF HONG KONG;CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING UNION MEDICAL COLLEGE;CANCER INSTITUTE & HOSPITAL - CAMS;BEIJING 307 PEOPLES LIBERAT ARMY HOSP CANC CTR;BAYER HEALTHCARE PHARMACEUTICALS;BAYER AG;
FUDAN UNIV, SHANGHAI CANC CTR, DEPT MED ONCOL, SHANGHAI 200433, PEOPLES R CHINA;FUDAN UNIV, SHANGHAI MED COLL, DEPT ONCOL, SHANGHAI 200433, PEOPLES R CHINA;NANJING BAYI HOSP, CHINESE PEOPLES LIBERAT ARMY CANC CTR, DEPT MED ONCOL, NANJING, JIANGSU, PEOPLES R CHINA;SUN YAT SEN UNIV, CTR CANC, DEPT MED ONCOL, COLLABORAT INNOVAT CTR CANC MED, GUANGZHOU 510275, GUANGDONG, PEOPLES R CHINA;UNIV HONG KONG, DEPT MED, QUEEN MARY HOSP, HONG KONG, HONG KONG, PEOPLES R CHINA;CHINESE UNIV HONG KONG, PRINCE WALES HOSP, DEPT CLIN ONCOL, HONG KONG, HONG KONG, PEOPLES R CHINA;ZHEJIANG UNIV, SIR RUN RUN SHAW HOSP, SCH MED, MED ONCOL, HANGZHOU 310003, ZHEJIANG, PEOPLES R CHINA;BEIJING 307 PEOPLES LIBERAT ARMY HOSP CANC CTR, BEIJING, PEOPLES R CHINA;HARBIN MED UNIV, AFFILIATED HOSP 3, HARBIN, PEOPLES R CHINA;CHINESE ACAD MED SCI, CANC HOSP, DEPT MED ONCOL, BEIJING 100730, PEOPLES R CHINA;SHANGHAI JIAO TONG UNIV, SHANGHAI PEOPLES HOSP 1, CTR COMPREHENS CANC, SHANGHAI, PEOPLES R CHINA;NATL TAIWAN UNIV HOSP, DEPT ONCOL, TAIPEI, TAIWAN;SICHUAN UNIV, WEST CHINA HOSP, DEPT MED ONCOL, CHENGDU 610064, PEOPLES R CHINA;JILIN PROV TUMOR HOSP, CHANGCHUN, PEOPLES R CHINA;CHO RAY HOSP, DEPT ONCOL, HO CHI MINH CITY, VIETNAM;NATL YANG MING UNIV, TAIPEI VET GEN HOSP, DEPT SURG, TAIPEI 112, TAIWAN;FUDAN UNIV, ZHONG SHAN HOSP, DEPT MED ONCOL, SHANGHAI 200433, PEOPLES R CHINA;GUANGDONG GEN HOSP, DEPT MED ONCOL, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;BAYER PHARMA AG, BERLIN, GERMANY;UNIV ULSAN, COLL MED, ASAN MED CTR, DEPT ONCOL, ULSAN, SOUTH KOREA
|
LANCET ONCOLOGY 16 (6): 619-629 JUN 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
469 |
|
高被引论文
2024-03
|
WOS:000356055600012
MEDLINE:25624438 |
DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING SURVIVAL IN PATIENTS WITH RESECTED NON-SMALL-CELL LUNG CANCER
DOI
LIANG, WH;ZHANG, L;JIANG, GN;WANG, Q;LIU, LX;LIU, DR;WANG, Z;ZHU, ZH;DENG, QH;XIONG, XG;SHAO, WL;SHI, XS;HE, JX
NA-CHINA STATE KEY LAB RESP;TONGJI UNIVERSITY;SUN YAT SEN UNIVERSITY;SICHUAN UNIVERSITY;JINAN UNIVERSITY;GUANGZHOU MEDICAL UNIVERSITY;GUANGZHOU INST RESP DIS;FUDAN UNIVERSITY;CHINA-JAPAN FRIENDSHIP HOSPITAL;
GUANGZHOU MED UNIV, AFFILIATED HOSP 1, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;GUANGZHOU INST RESP DIS, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;CHINA STATE KEY LAB RESP, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;SUN YAT SEN UNIV, CTR CANC, GUANGZHOU 510275, GUANGDONG, PEOPLES R CHINA;TONGJI UNIV, SHANGHAI PULM HOSP, SHANGHAI, PEOPLES R CHINA;FUDAN UNIV, SHANGHAI ZHONGSHAN HOSP, SHANGHAI 200433, PEOPLES R CHINA;SICHUAN UNIV, WEST CHINA HOSP, CHENGDU 610064, PEOPLES R CHINA;CHINA & JAPAN FRIENDSHIP HOSP, BEIJING, PEOPLES R CHINA;SHENZHEN PEOPLES HOSP, SHENZHEN, PEOPLES R CHINA
|
JOURNAL OF CLINICAL ONCOLOGY 33 (8): 861-+ MAR 10 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
441 |
|
高被引论文
2024-03
|
WOS:000347810300050
MEDLINE:25363763 |
CEACAM1 REGULATES TIM-3-MEDIATED TOLERANCE AND EXHAUSTION
DOI
HUANG, YH;ZHU, C;KONDO, Y;ANDERSON, AC;GANDHI, A;RUSSELL, A;DOUGAN, SK;PETERSEN, BS;MELUM, E;PERTEL, T;CLAYTON, KL;RAAB, M;CHEN, Q;BEAUCHEMIN, N;YAZAKI, PJ;PYZIK, M;OSTROWSKI, MA;GLICKMAN, JN;RUDD, CE;PLOEGH, HL;FRANKE, A;PETSKO, GA;KUCHROO, VK;BLUMBERG,
BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE;WHITEHEAD INSTITUTE;UNIVERSITY OF TORONTO;UNIVERSITY OF OSLO;UNIVERSITY OF KIEL;UNIVERSITY OF CAMBRIDGE;UNIV TORONTO AFFILIATES;SICHUAN UNIVERSITY;SAINT MICHAELS HOSPITAL TORONTO;MIRACA LIFE SCI;MCGILL UNIVERSITY;MASSACHUSETTS INSTITUTE OF TECHNOLOGY (MIT);HARVARD UNIVERSITY;HARVARD UNIV MEDICAL AFFILIATES;HARVARD MEDICAL SCHOOL;CITY OF HOPE;BRIGHAM & WOMEN'S HOSPITAL;BRANDEIS UNIVERSITY;
HARVARD UNIV, SCH MED, DEPT MED, DIV GASTROENTEROL,BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA;HARVARD UNIV, SCH MED, EVERGRANDE CTR IMMUNOL DIS, BOSTON, MA 02115 USA;BRIGHAM & WOMENS HOSP, HARVARD INST MED, BOSTON, MA 02115 USA;BRANDEIS UNIV, ROSENSTIEL BASIC MED SCI RES CTR, WALTHAM, MA 02454 USA;MIT, WHITEHEAD INST, CAMBRIDGE, MA 02142 USA;UNIV KIEL, INST CLIN MOL BIOL, D-24105 KIEL, GERMANY;OSLO UNIV HOSP, NORWEGIAN PSC RES CTR, DIV CANC MED SURG & TRANSPLANTAT, N-0424 OSLO, NORWAY;UNIV TORONTO, DEPT IMMUNOL, TORONTO, ON M5S 1A8, CANADA;UNIV CAMBRIDGE, DEPT PATHOL, CELL SIGNALLING SECT, CAMBRIDGE CB2 1QP, ENGLAND;SICHUAN UNIV, WEST CHINA HOSP, STATE KEY LAB BIOTHERAPY, CHENGDU 610041, PEOPLES R CHINA;MCGILL UNIV, GOODMAN CANC RES CTR, MONTREAL, PQ H3G 1Y6, CANADA;CITY HOPE NATL MED CTR, BECKMAN INST, DUARTE, CA 91010 USA;ST MICHAELS HOSP, KEENAN RES CTR, TORONTO, ON M5S 1A8, CANADA;MIRACA LIFE SCI, GI PATHOL, NEWTON, MA 02464 USA
|
NATURE 517 (7534): 386-U566 JAN 15 2015 | 2015 |
免疫学
IMMUNOLOGY |
413 |
|
高被引论文
2024-03
|
WOS:000367644000001
MEDLINE:26558141 |
NANOMATERIALS AND BONE REGENERATION
DOI
GONG, T;XIE, J;LIAO, JF;ZHANG, T;LIN, SY;LIN, YF
SICHUAN UNIVERSITY;
SICHUAN UNIV, WEST CHINA HOSP STOMATOL, STATE KEY LAB ORAL DIS, CHENGDU 610041, PEOPLES R CHINA
|
BONE RESEARCH 3: - NOV 10 2015 | 2015 |
生物学与生物化学
BIOLOGY & BIOCHEMISTRY |
408 |
|
高被引论文
2024-03
|
WOS:000356177100009
MEDLINE:25643002 |
EFFECTIVENESS OF MULTICOMPONENT NONPHARMACOLOGICAL DELIRIUM INTERVENTIONS A META-ANALYSIS
DOI
HSHIEH, TT;YUE, JR;OH, E;PUELLE, M;DOWAL, S;TRAVISON, T;INOUYE, SK
BETH ISRAEL DEACONESS MEDICAL CENTER;SICHUAN UNIVERSITY;JOHNS HOPKINS UNIVERSITY;JOHNS HOPKINS MEDICINE;HEBREW SENIORLIFE;HARVARD UNIVERSITY;HARVARD UNIV MEDICAL AFFILIATES;HARVARD MEDICAL SCHOOL;BRIGHAM & WOMEN'S HOSPITAL;
HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV AGING, BOSTON, MA 02115 USA;HEBREW SENIORLIFE, INST AGING RES, AGING BRAIN CTR, BOSTON, MA USA;SICHUAN UNIV, WEST CHINA HOSP, DEPT GERIATR, CHENGDU 610064, PEOPLES R CHINA;JOHNS HOPKINS SCH MED, DIV GERIATR MED & GERONTOL, BALTIMORE, MD USA;HARVARD UNIV, BETH ISRAEL DEACONESS MED CTR, SCH MED, DEPT MED, BOSTON, MA 02215 USA
|
JAMA INTERNAL MEDICINE 175 (4): 512-520 APR 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
404 |
|
高被引论文
2024-03
|
WOS:000365464800096
MEDLINE:26458137 |
SELF-TARGETING FLUORESCENT CARBON DOTS FOR DIAGNOSIS OF BRAIN CANCER CELLS
DOI
ZHENG, M;RUAN, SB;LIU, S;SUN, TT;QU, D;ZHAO, HF;XIE, ZG;GAO, HL;JING, XB;SUN, ZC
BEIJING UNIVERSITY OF TECHNOLOGY;UNIVERSITY OF CHINESE ACADEMY OF SCIENCES, CAS;SICHUAN UNIVERSITY;CHINESE ACADEMY OF SCIENCES;CHANGCHUN UNIVERSITY OF TECHNOLOGY;CHANGCHUN INSTITUTE OF OPTICS, FINE MECHANICS & PHYSICS, CAS;CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY, CAS;
CHANGCHUN UNIV TECHNOL, ADV INST MAT SCI, CHEM & LIFE SCI SCH, CHANGCHUN 130012, JILIN, PEOPLES R CHINA;CHINESE ACAD SCI, CHANGCHUN INST OPT FINE MECH & PHYS, STATE KEY LAB LUMINESCENCE & APPLICAT, CHANGCHUN 130033, JILIN, PEOPLES R CHINA;CHINESE ACAD SCI, CHANGCHUN INST APPL CHEM, STATE KEY LAB POLYMER PHYS & CHEM, CHANGCHUN 130022, JILIN, PEOPLES R CHINA;SICHUAN UNIV, WEST CHINA SCH PHARM, KEY LAB DRUG TARGETING & DRUG DELIVERY SYST, CHENGDU 610041, PEOPLES R CHINA;UNIV CHINESE ACAD SCI, BEIJING 100049, PEOPLES R CHINA;BEIJING UNIV TECHNOL, DEPT CHEM & CHEM ENGN, BEIJING KEY LAB GREEN CATALYSIS & SEPARAT, BEIJING 100124, PEOPLES R CHINA
|
ACS NANO 9 (11): 11455-11461 NOV 2015 | 2015 |
材料科学
MATERIALS SCIENCE |
373 |
|
高被引论文
2024-03
|
WOS:000359956200007
MEDLINE:26206723 |
BAT-TO-HUMAN: SPIKE FEATURES DETERMINING HOST JUMP OF CORONAVIRUSES SARS-COV, MERS-COV, AND BEYOND
DOI
LU, GW;WANG, QH;GAO, GF
CHINESE ACADEMY OF SCIENCES;SICHUAN UNIVERSITY;INSTITUTE OF MICROBIOLOGY, CAS;CHINESE CENTER FOR DISEASE CONTROL & PREVENTION;
CHINESE ACAD SCI, INST MICROBIOL, CAS KEY LAB PATHOGEN MICROBIOL & IMMUNOL, BEIJING 100101, PEOPLES R CHINA;SICHUAN UNIV, WEST CHINA MED SCH, WEST CHINA HOSP, STATE KEY LAB BIOTHERAPY, CHENGDU 610041, SICHUAN, PEOPLES R CHINA;SICHUAN UNIV, WEST CHINA MED SCH, WEST CHINA HOSP, CTR CANC, CHENGDU 610041, SICHUAN, PEOPLES R CHINA;CHINESE ACAD SCI, INST MICROBIOL, CAS KEY LAB MICROBIAL PHYSIOL & METAB ENGN, BEIJING 100101, PEOPLES R CHINA;CHINESE CTR DIS CONTROL & PREVENT CHINA CDC, OFF DIRECTOR GEN, BEIJING 102206, PEOPLES R CHINA
|
TRENDS IN MICROBIOLOGY 23 (8): 468-478 AUG 2015 | 2015 |
微生物学
MICROBIOLOGY |
344 |
|
高被引论文
2024-03
|
WOS:000350185400010
|
QUALITATIVE DECISION MAKING WITH CORRELATION COEFFICIENTS OF HESITANT FUZZY LINGUISTIC TERM SETS
DOI
LIAO, HC;XU, ZS;ZENG, XJ;MERIGÓ, JM
SICHUAN UNIVERSITY;UNIVERSITY OF MANCHESTER;UNIVERSIDAD DE CHILE;
SICHUAN UNIV, SCH BUSINESS, CHENGDU 610065, SICHUAN, PEOPLES R CHINA;UNIV MANCHESTER, SCH COMP SCI, MANCHESTER M13 9PL, LANCS, ENGLAND;UNIV CHILE, DEPT MANAGEMENT CONTROL & INFORMAT SYST, SANTIAGO 8330015, CHILE
|
KNOWLEDGE-BASED SYSTEMS 76: 127-138 MAR 2015 | 2015 |
计算机科学
COMPUTER SCIENCE |
333 |
|
高被引论文
2024-03
|
WOS:000347005100036
MEDLINE:25132233 |
COMPARISON OF DIAGNOSTIC ACCURACY OF ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX AND FIBROSIS-4 INDEX FOR DETECTING LIVER FIBROSIS IN ADULT PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION: A SYSTEMIC REVIEW AND META-ANALYSIS
DOI
XIAO, GQ;YANG, JY;YAN, LA
SICHUAN UNIVERSITY;
SICHUAN UNIV, DEPT LIVER SURG, WEST CHINA HOSP, CHENGDU 610041, SICHUAN PROVINC, PEOPLES R CHINA;SICHUAN UNIV, ORGAN TRANSPLANTAT CTR, WEST CHINA HOSP, CHENGDU 610041, SICHUAN PROVINC, PEOPLES R CHINA
|
HEPATOLOGY 61 (1): 292-302 JAN 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
326 |
|
高被引论文
2024-03
|
WOS:000368472700005
MEDLINE:26511917 |
ETHYLENE CONTROL OF FRUIT RIPENING: REVISITING THE COMPLEX NETWORK OF TRANSCRIPTIONAL REGULATION
DOI
LIU, MC;PIRRELLO, J;CHERVIN, C;ROUSTAN, JP;BOUZAYEN, M
AGROCAMPUS OUEST;UNIVERSITE FEDERALE TOULOUSE MIDI-PYRENEES (COMUE);UNIVERSITE DE TOULOUSE;UNIV BRETAGNE LOIRE;SICHUAN UNIVERSITY;PRES EUROPEAN UNIV BRETAGNE;INSTITUT NATIONAL POLYTECHNIQUE DE TOULOUSE;INSTITUT AGRO;INRAE;
SICHUAN UNIV, COLL LIFE SCI, KEY LAB BIORESOURCE & ECOENVIRONM, STATE KEY LAB HYDRAUL & MT RIVER ENGN,MINIST EDUC, CHENGDU 610064, PEOPLES R CHINA;UNIV TOULOUSE, INST NATL POLYTECH TOULOUSE, ECOLE NATL SUPER AGRON, GENOM & BIOTECHNOL FRUITS UMR990, F-31326 CASTANET TOLOSAN, FRANCE;INRA, GENOM & BIOTECHNOL FRUITS UMR990, F-31326 CASTANET TOLOSAN, FRANCE
|
PLANT PHYSIOLOGY 169 (4): 2380-2390 DEC 2015 | 2015 |
植物学与动物学
PLANT & ANIMAL SCIENCE |
316 |
|
高被引论文
2024-03
|
WOS:000346845500011
MEDLINE:25444171 |
DEPRESSION, NEUROIMAGING AND CONNECTOMICS: A SELECTIVE OVERVIEW
DOI
GONG, QY;HE, Y
BEIJING NORMAL UNIVERSITY;YALE UNIVERSITY;SICHUAN UNIVERSITY;
SICHUAN UNIV, HUAXI MAGNET RESONANCE RES CTR, DEPT RADIOL, CTR MED IMAGING,WEST CHINA HOSP, CHENGDU 610064, PEOPLES R CHINA;YALE UNIV, SCH MED, DEPT PSYCHIAT, NEW HAVEN, CT USA;SICHUAN UNIV, DEPT PSYCHIAT, STATE KEY LAB BIOTHERAPY, WEST CHINA HOSP, CHENGDU 610064, PEOPLES R CHINA;BEIJING NORMAL UNIV, STATE KEY LAB COGNIT NEUROSCI & LEARNING, BEIJING 100875, PEOPLES R CHINA;BEIJING NORMAL UNIV, INT DIGITAL GRP, MCGOVERN INST BRAIN RES, BEIJING 100875, PEOPLES R CHINA;BEIJING NORMAL UNIV, CTR COLLABORAT & INNOVAT BRAIN & LEARNING SCI, BEIJING 100875, PEOPLES R CHINA
|
BIOLOGICAL PSYCHIATRY 77 (3): 223-235 FEB 1 2015 | 2015 |
神经科学与行为科学
NEUROSCIENCE & BEHAVIOR |
305 |
|
高被引论文
2024-03
|
WOS:000362582800002
|
HESITANT FUZZY LINGUISTIC VIKOR METHOD AND ITS APPLICATION IN QUALITATIVE MULTIPLE CRITERIA DECISION MAKING
DOI
LIAO, HC;XU, ZS;ZENG, XJ
SHANGHAI JIAO TONG UNIVERSITY;UNIVERSITY OF MANCHESTER;SICHUAN UNIVERSITY;
SHANGHAI JIAO TONG UNIV, ANTAI COLL ECON & MANAGEMENT, SHANGHAI 200052, PEOPLES R CHINA;SICHUAN UNIV, SCH BUSINESS, CHENGDU 610064, PEOPLES R CHINA;UNIV MANCHESTER, SCH COMP SCI, MANCHESTER M13 9PL, LANCS, ENGLAND
|
IEEE TRANSACTIONS ON FUZZY SYSTEMS 23 (5): 1343-1355 OCT 2015 | 2015 |
工程学
ENGINEERING |
301 |
|
高被引论文
2024-03
|
WOS:000356636300003
|
STAR POLYMERS: ADVANCES IN BIOMEDICAL APPLICATIONS
DOI
WU, W;WANG, WG;LI, JS
SICHUAN UNIVERSITY;
SICHUAN UNIV, COLL POLYMER SCI & ENGN, CHENGDU 610065, PEOPLES R CHINA;SICHUAN UNIV, STATE KEY LAB POLYMER MAT ENGN, CHENGDU 610065, PEOPLES R CHINA
|
PROGRESS IN POLYMER SCIENCE 46: 55-85 JUL 2015 | 2015 |
化学
CHEMISTRY |
296 |
|
高被引论文
2024-03
|
WOS:000358554700051
MEDLINE:26159065 |
GEFITINIB PLUS CHEMOTHERAPY VERSUS PLACEBO PLUS CHEMOTHERAPY IN EGFR-MUTATION- POSITIVE NON-SMALL-CELL LUNG CANCER AFTER PROGRESSION ON FIRST-LINE GEFITINIB (IMPRESS): A PHASE 3 RANDOMISED TRIAL
DOI
SORIA, JC;WU, YL;NAKAGAWA, K;KIM, SW;YANG, JJ;AHN, MJ;WANG, J;YANG, JCH;LU, Y;ATAGI, S;PONCE, S;LEE, DH;LIU, YP;YOH, K;ZHOU, JY;SHI, XJ;WEBSTER, A;JIANG, HY;MOK, TSK
ASAN MEDICAL CENTER;ZHEJIANG UNIVERSITY;UNIVERSITY OF ULSAN;UNIVERSITE PARIS SACLAY;UNIV PARIS SACLAY COMUE;UDICE FRENCH RES UNIV;SUNGKYUNKWAN UNIVERSITY (SKKU);SICHUAN UNIVERSITY;SAMSUNG MEDICAL CENTER;PRINCE OF WALES HOSPITAL;PEKING UNIVERSITY;NATIONAL TAIWAN UNIVERSITY HOSPITAL;NATIONAL TAIWAN UNIVERSITY;NATIONAL CANCER CENTER - JAPAN;KINKI CHUO CHEST MED CTR;KINDAI UNIVERSITY (KINKI UNIVERSITY);HOSPITAL UNIVERSITARIO 12 DE OCTUBRE;GUANGDONG ACADEMY OF MEDICAL SCIENCES & GUANGDONG GENERAL HOSPITAL;DEPT MED;CHINESE UNIVERSITY OF HONG KONG;CHINA MED UNIV;ASTRAZENECA;
DEPT MED, VILLEJUIF, FRANCE;UNIV PARIS 11, VILLEJUIF, FRANCE;GUANGDONG GEN HOSP, GUANGDONG LUNG CANC INST, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;GUANGDONG ACAD MED SCI, GUANGZHOU, GUANGDONG, PEOPLES R CHINA;KINKI UNIV, FAC MED, DEPT MED ONCOL, OSAKASAYAMA CITY, OSAKA, JAPAN;UNIV ULSAN, COLL MED, ASAN MED CTR, DEPT ONCOL, SEOUL, SOUTH KOREA;SUNGKYUNKWAN UNIV, SCH MED, SAMSUNG MED CTR, DIV HEMATOL ONCOL,DEPT MED, SEOUL, SOUTH KOREA;PEKING UNIV, SCH ONCOL, BEIJING CANC HOSP & INST, DEPT THORAC MED ONCOL, BEIJING 100871, PEOPLES R CHINA;NATL TAIWAN UNIV HOSP, COLL MED, DEPT ONCOL, TAIPEI, TAIWAN;SICHUAN UNIV, DEPT THORAC CANC, CTR CANC, WEST CHINA HOSP,WEST CHINA MED SCH, CHENGDU, SICHUAN, PEOPLES R CHINA;KINKI CHUO CHEST MED CTR, DEPT THORAC ONCOL, OSAKA, JAPAN;HOSP UNIV 12 OCTUBRE, MED ONCOL SERV, MADRID, SPAIN;CHINA MED UNIV, DEPT MED ONCOL, HOSP 1, SHENGYANG CITY, PEOPLES R CHINA;NATL CANC CTR HOSP EAST, DIV THORAC ONCOL, CHIBA, JAPAN;ZHEJIANG UNIV, COLL MED, AFFILIATED HOSP 1, DEPT RESP DIS, HANGZHOU, ZHEJIANG, PEOPLES R CHINA;ASTRAZENECA, SHANGHAI, PEOPLES R CHINA;ASTRAZENECA, MACCLESFIELD, ENGLAND;CHINESE UNIV HONG KONG, PRINCE WALES HOSP, STATE KEY LAB SOUTH CHINA, HONG KONG CANC INST,DEPT CLIN ONCOL, SHA TIN, HONG KONG, PEOPLES R CHINA
|
LANCET ONCOLOGY 16 (8): 990-998 AUG 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
291 |
|
高被引论文
2024-03
|
WOS:000350304500010
MEDLINE:25738670 |
BORTEZOMIB-BASED THERAPY FOR NEWLY DIAGNOSED MANTLE-CELL LYMPHOMA
DOI
ROBAK, T;HUANG, HQ;JIN, J;ZHU, J;LIU, T;SAMOILOVA, O;PYLYPENKO, H;VERHOEF, G;SIRITANARATKUL, N;OSMANOV, E;ALEXEEVA, J;PEREIRA, J;DRACH, J;MAYER, J;HONG, XN;OKAMOTO, R;PEI, LX;ROONEY, B;VAN DE VELDE, H;CAVALLI, F
NA-CHERKASSY REG ONCOL CTR;ZHEJIANG UNIVERSITY;UNIVERSITY HOSPITAL LEUVEN;UNIVERSITY HOSPITAL BRNO;UNIVERSIDADE DE SAO PAULO;TOKYO METROPOLITAN CANCER & INFECTIOUS DISEASES CENTER KOMAGOME HOSPITAL;SUN YAT SEN UNIVERSITY;SICHUAN UNIVERSITY;RUSSIAN ACADEMY OF MEDICAL SCIENCES;REGIONAL HOSPITAL OF BELLINZONA & VALLEYS, SAN GIOVANNI;PEKING UNIVERSITY;NIZHNY NOVGOROD REGION CLIN HOSP;MEDICAL UNIVERSITY OF VIENNA;MEDICAL UNIVERSITY LODZ;MAHIDOL UNIVERSITY;KU LEUVEN;JOHNSON & JOHNSON;JANSSEN PHARMACEUTICALS;INSTITUTE OF ONCOLOGY RESEARCH (IOR);FUDAN UNIVERSITY;FED CTR HEART BLOOD & ENDOCRINOL;
MED UNIV LODZ, DEPT HEMATOL, COPERNICUS MEM HOSP, LODZ, POLAND;SUN YAT SEN UNIV, CTR CANC, GUANGZHOU 510275, GUANGDONG, PEOPLES R CHINA;ZHEJIANG UNIV, COLL MED, DEPT HEMATOL, AFFILIATED HOSP 1, HANGZHOU 310003, ZHEJIANG, PEOPLES R CHINA;BEIJING CANC HOSP, DEPT LYMPHAT ONCOL, BEIJING, PEOPLES R CHINA;SICHUAN UNIV, DEPT HEMATOL, WEST CHINA HOSP, CHENGDU 610064, PEOPLES R CHINA;FUDAN UNIV, SHANGHAI CANC CTR, DEPT MED ONCOL, SHANGHAI 200433, PEOPLES R CHINA;NIZHNY NOVGOROD REGION CLIN HOSP, NIZHNII NOVGOROD, RUSSIA;RUSSIAN ACAD MED SCI, CANC RES CTR, NN BLOKHIN ACAD MED SCI, MOSCOW, RUSSIA;FED CTR HEART BLOOD & ENDOCRINOL, ST PETERSBURG, RUSSIA;CHERKASSY REG ONCOL CTR, DEPT HEMATOL, CHERKASSY, UKRAINE;UNIV HOSP LEUVEN, DEPT HEMATOL, LEUVEN, BELGIUM;JANSSEN RES & DEV, BEERSE, BELGIUM;MAHIDOL UNIV, FAC SCI, SIRIRAJ HOSP, DEPT MED, BANGKOK 10400, THAILAND;UNIV SAO PAULO, FAC MED, HOSP CLIN, BR-09500900 SAO PAULO, BRAZIL;MED UNIV VIENNA, VIENNA GEN HOSP, DIV ONCOL, DEPT INTERNAL MED 1, VIENNA, AUSTRIA;FAC HOSP BRNO, DEPT INTERNAL MED HEMATOL & ONCOL, BRNO, CZECH REPUBLIC;KOMAGOME HOSP, TOKYO METROPOLITAN CANC & INFECT DIS CTR, DEPT CHEMOTHERAPY, TOKYO, JAPAN;JANSSEN RES & DEV, RARITAN, NJ USA;JANSSEN CILAG, JANSSEN RES & DEV, HIGH WYCOMBE, BUCKS, ENGLAND;OSPED SAN GIOVANNI BELLINZONA, ONCOL INST SOUTHERN SWITZERLAND, CH-6500 BELLINZONA, SWITZERLAND
|
NEW ENGLAND JOURNAL OF MEDICINE 372 (10): 944-953 MAR 5 2015 | 2015 |
临床医学
CLINICAL MEDICINE |
276 |
服务时间 |
联系方式
|